Artificial Lung Market Size, Share, Growth, Analysis, 2034

Download Free Sample

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Artificial Lung Market Size Analysis

Global Artificial Lung Market Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Extracorporeal Membrane Oxygenation (ECMO) Systems
  1. By Value
3. Paracorporeal Artificial Lungs
  1. By Value
4. Intracorporeal Artificial Lungs
  1. By Value
5. Membrane Oxygenators
  1. By Value
6. Portable Artificial Lungs
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Bridge-to-Transplantation
  1. By Value
3. Bridge-to-Recovery
  1. By Value
4. ECMO-assisted Ventilation
  1. By Value
5. Pulmonary Rehabilitation
  1. By Value
6. Long-term Support for Chronic Lung Diseases
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Tertiary Care Hospitals
  1. By Value
3. Transplant Centers
  1. By Value
4. Research Institutions and Clinical Trial Sites
  1. By Value
5. Specialty Respiratory Clinics
  1. By Value

North America Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Extracorporeal Membrane Oxygenation (ECMO) Systems
  1. By Value
3. Paracorporeal Artificial Lungs
  1. By Value
4. Intracorporeal Artificial Lungs
  1. By Value
5. Membrane Oxygenators
  1. By Value
6. Portable Artificial Lungs
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Bridge-to-Transplantation
  1. By Value
3. Bridge-to-Recovery
  1. By Value
4. ECMO-assisted Ventilation
  1. By Value
5. Pulmonary Rehabilitation
  1. By Value
6. Long-term Support for Chronic Lung Diseases
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Tertiary Care Hospitals
  1. By Value
3. Transplant Centers
  1. By Value
4. Research Institutions and Clinical Trial Sites
  1. By Value
5. Specialty Respiratory Clinics
  1. By Value
U.S.
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Extracorporeal Membrane Oxygenation (ECMO) Systems
    1. By Value
  3. Paracorporeal Artificial Lungs
    1. By Value
  4. Intracorporeal Artificial Lungs
    1. By Value
  5. Membrane Oxygenators
    1. By Value
  6. Portable Artificial Lungs
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Bridge-to-Transplantation
    1. By Value
  3. Bridge-to-Recovery
    1. By Value
  4. ECMO-assisted Ventilation
    1. By Value
  5. Pulmonary Rehabilitation
    1. By Value
  6. Long-term Support for Chronic Lung Diseases
    1. By Value
3. By End User
  1. Introduction
    1. End User By Value
  2. Tertiary Care Hospitals
    1. By Value
  3. Transplant Centers
    1. By Value
  4. Research Institutions and Clinical Trial Sites
    1. By Value
  5. Specialty Respiratory Clinics
    1. By Value
Canada

Europe Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Extracorporeal Membrane Oxygenation (ECMO) Systems
  1. By Value
3. Paracorporeal Artificial Lungs
  1. By Value
4. Intracorporeal Artificial Lungs
  1. By Value
5. Membrane Oxygenators
  1. By Value
6. Portable Artificial Lungs
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Bridge-to-Transplantation
  1. By Value
3. Bridge-to-Recovery
  1. By Value
4. ECMO-assisted Ventilation
  1. By Value
5. Pulmonary Rehabilitation
  1. By Value
6. Long-term Support for Chronic Lung Diseases
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Tertiary Care Hospitals
  1. By Value
3. Transplant Centers
  1. By Value
4. Research Institutions and Clinical Trial Sites
  1. By Value
5. Specialty Respiratory Clinics
  1. By Value
U.K.
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Extracorporeal Membrane Oxygenation (ECMO) Systems
    1. By Value
  3. Paracorporeal Artificial Lungs
    1. By Value
  4. Intracorporeal Artificial Lungs
    1. By Value
  5. Membrane Oxygenators
    1. By Value
  6. Portable Artificial Lungs
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Bridge-to-Transplantation
    1. By Value
  3. Bridge-to-Recovery
    1. By Value
  4. ECMO-assisted Ventilation
    1. By Value
  5. Pulmonary Rehabilitation
    1. By Value
  6. Long-term Support for Chronic Lung Diseases
    1. By Value
3. By End User
  1. Introduction
    1. End User By Value
  2. Tertiary Care Hospitals
    1. By Value
  3. Transplant Centers
    1. By Value
  4. Research Institutions and Clinical Trial Sites
    1. By Value
  5. Specialty Respiratory Clinics
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Extracorporeal Membrane Oxygenation (ECMO) Systems
  1. By Value
3. Paracorporeal Artificial Lungs
  1. By Value
4. Intracorporeal Artificial Lungs
  1. By Value
5. Membrane Oxygenators
  1. By Value
6. Portable Artificial Lungs
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Bridge-to-Transplantation
  1. By Value
3. Bridge-to-Recovery
  1. By Value
4. ECMO-assisted Ventilation
  1. By Value
5. Pulmonary Rehabilitation
  1. By Value
6. Long-term Support for Chronic Lung Diseases
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Tertiary Care Hospitals
  1. By Value
3. Transplant Centers
  1. By Value
4. Research Institutions and Clinical Trial Sites
  1. By Value
5. Specialty Respiratory Clinics
  1. By Value
China
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Extracorporeal Membrane Oxygenation (ECMO) Systems
    1. By Value
  3. Paracorporeal Artificial Lungs
    1. By Value
  4. Intracorporeal Artificial Lungs
    1. By Value
  5. Membrane Oxygenators
    1. By Value
  6. Portable Artificial Lungs
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Bridge-to-Transplantation
    1. By Value
  3. Bridge-to-Recovery
    1. By Value
  4. ECMO-assisted Ventilation
    1. By Value
  5. Pulmonary Rehabilitation
    1. By Value
  6. Long-term Support for Chronic Lung Diseases
    1. By Value
3. By End User
  1. Introduction
    1. End User By Value
  2. Tertiary Care Hospitals
    1. By Value
  3. Transplant Centers
    1. By Value
  4. Research Institutions and Clinical Trial Sites
    1. By Value
  5. Specialty Respiratory Clinics
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Extracorporeal Membrane Oxygenation (ECMO) Systems
  1. By Value
3. Paracorporeal Artificial Lungs
  1. By Value
4. Intracorporeal Artificial Lungs
  1. By Value
5. Membrane Oxygenators
  1. By Value
6. Portable Artificial Lungs
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Bridge-to-Transplantation
  1. By Value
3. Bridge-to-Recovery
  1. By Value
4. ECMO-assisted Ventilation
  1. By Value
5. Pulmonary Rehabilitation
  1. By Value
6. Long-term Support for Chronic Lung Diseases
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Tertiary Care Hospitals
  1. By Value
3. Transplant Centers
  1. By Value
4. Research Institutions and Clinical Trial Sites
  1. By Value
5. Specialty Respiratory Clinics
  1. By Value
UAE
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Extracorporeal Membrane Oxygenation (ECMO) Systems
    1. By Value
  3. Paracorporeal Artificial Lungs
    1. By Value
  4. Intracorporeal Artificial Lungs
    1. By Value
  5. Membrane Oxygenators
    1. By Value
  6. Portable Artificial Lungs
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Bridge-to-Transplantation
    1. By Value
  3. Bridge-to-Recovery
    1. By Value
  4. ECMO-assisted Ventilation
    1. By Value
  5. Pulmonary Rehabilitation
    1. By Value
  6. Long-term Support for Chronic Lung Diseases
    1. By Value
3. By End User
  1. Introduction
    1. End User By Value
  2. Tertiary Care Hospitals
    1. By Value
  3. Transplant Centers
    1. By Value
  4. Research Institutions and Clinical Trial Sites
    1. By Value
  5. Specialty Respiratory Clinics
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Extracorporeal Membrane Oxygenation (ECMO) Systems
  1. By Value
3. Paracorporeal Artificial Lungs
  1. By Value
4. Intracorporeal Artificial Lungs
  1. By Value
5. Membrane Oxygenators
  1. By Value
6. Portable Artificial Lungs
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Bridge-to-Transplantation
  1. By Value
3. Bridge-to-Recovery
  1. By Value
4. ECMO-assisted Ventilation
  1. By Value
5. Pulmonary Rehabilitation
  1. By Value
6. Long-term Support for Chronic Lung Diseases
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Tertiary Care Hospitals
  1. By Value
3. Transplant Centers
  1. By Value
4. Research Institutions and Clinical Trial Sites
  1. By Value
5. Specialty Respiratory Clinics
  1. By Value
Brazil
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Extracorporeal Membrane Oxygenation (ECMO) Systems
    1. By Value
  3. Paracorporeal Artificial Lungs
    1. By Value
  4. Intracorporeal Artificial Lungs
    1. By Value
  5. Membrane Oxygenators
    1. By Value
  6. Portable Artificial Lungs
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Bridge-to-Transplantation
    1. By Value
  3. Bridge-to-Recovery
    1. By Value
  4. ECMO-assisted Ventilation
    1. By Value
  5. Pulmonary Rehabilitation
    1. By Value
  6. Long-term Support for Chronic Lung Diseases
    1. By Value
3. By End User
  1. Introduction
    1. End User By Value
  2. Tertiary Care Hospitals
    1. By Value
  3. Transplant Centers
    1. By Value
  4. Research Institutions and Clinical Trial Sites
    1. By Value
  5. Specialty Respiratory Clinics
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Artificial Lung Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Medtronic (Ireland)
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Getinge AB (Sweden)
Terumo Corporation (Japan)
Abbott Laboratories (US)
Abiomed (US)
Fresenius Medical Care (Germany)
Xenios AG (Germany)
LivaNova PLC (UK)
Eurosets S.r.l. (Italy)
Nipro Corporation (Japan)
MicroPort Scientific Corporation (China)
Spectrum Medical (UK)
SB-Kawasumi Laboratories (Japan)
Senko Medical Instrument Mfg. Co., Ltd. (Japan)
Braile Biomedica (Brazil)
Hemovent GmbH (Germany)
ALung Technologies (US)
Lung Biotechnology PBC (US)

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment

Appendix

Discussion Guide
Customization Options
Related Reports

Disclaimer

Get This Report

Our Clients:

Hindustan National Glass & Industries Limited

Table Of Content

Download Free Sample

Debashree B

Healthcare Lead